Human Papilloma Virus Detection by INNOLiPA HPV in Prostate Tissue from Men of Northeast Mexico |
Rodriguez, Martha I Davila
(Department of Genetics, Centro De Investigacion Biomedica Del Noreste, Instituto Mexicano Del Seguro Social)
Morales, Cesar V Ignacio (Department of Urology. Unidad Medica de Alta Especialidad No. 25) Tovar, Anel R Aragon (Department of Urology. Unidad Medica de Alta Especialidad No. 25) Jimenez, Delia Olache (Hospital General de Zona No. 33, IMSS) Maldonado, Edmundo Castelan (Hospital General de Zona No. 33, IMSS) Miranda, Sandra Lara (Hospital General de Zona No. 33, IMSS) Gutierrez, Elva I Cortes (Department of Genetics, Centro De Investigacion Biomedica Del Noreste, Instituto Mexicano Del Seguro Social) |
1 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. DOI |
2 | Strickler HD, Burk R, Shah K, et al (1998). A multifaceted study of human papillomavirus and prostate carcinoma. Cancer, 82, 1118-25. DOI |
3 | Yang L, Xie S, Feng X, et al (2015). Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis. Sci Rep, 5, 14667. DOI |
4 | Sfanos KS, Isaacs WB, De Marzo AM (2013). Infections and inflammation in prostate cancer. Am J Clin Exp Urol, 25, 3-11. |
5 | Carozzi F, Lombardi FC, Zendron P, et al (2004). Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers, 19, 257-61. DOI |
6 | Adami HO, Kuper H, Andersson SO, Bergstrom R, Dillner J (2003). Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev, 12, 872-5. |
7 | Aghakhani A, Hamkar R, Parvin M, et al (2011). The role of Human papillomavirus infection in prostate carcinoma. Scand J Infect Dis, 43, 64-9. DOI |
8 | Anwar K, Nakakuki K, Shiraishi T, et al (1992). Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res, 52, 5991-6. |
9 | Araujo-Neto AP, Ferreira-Fernandes H, Amaral CM, et al (2016). Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil. Genet Mol Biol, 39, 24-9. DOI |
10 | Atashafrooz F, Rokhbakhsh-Zamin F (2016). Frequency and type distribution of human papilloma virus in patients with prostate cancer, kerman, southeast of Iran. Asian Pac J Cancer Prev, 17 , 3953-8 |
11 | Lazcano-Ponce E (2001). High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. STD, 28, 277-80. DOI |
12 | Dell G, Gaston K (2001). Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci, 58, 1923-42. DOI |
13 | Ghasemian E, Monavari SH, Irajian GR, et al (2013). Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran. Asian Pac J Cancer Prev, 14, 3305-8. DOI |
14 | Hrbacek J, Urban M, Hamsikova E, et al (2011). Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer, 11, 53. DOI |
15 | Marklund L, Hammarstedt L (2011). Impact of HPV in oropharyngeal cancer. J Oncol, 10, 509036. |
16 | Choo CK, Ling MT, Chan KW, et al (1999). Immortalization of human prostate epithe¬lial cells by HPV 16 E6/E7 open reading frames. Prostate, 40, 150-8. DOI |
17 | Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, et al (2010). Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer, 10, 326-30. DOI |
18 | McNicol PJ, Dodd JG (1990). Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol, 28, 409-12. |
19 | Medeiros F, Rigl CT, Anderson GG Becker SH, Halling KC (2007). Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch Pathol Lab Med, 131, 1805-16. |
20 | Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U (1999). Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.Cancer Res, 59, 823-5. |